The Mount Sinai Hospital has performed New York City’s first procedure using the HYDROS Robotic System, a cutting-edge technology designed to treat benign prostatic hyperplasia (BPH), or an enlarged prostate.
PDX engraftment predicts high recurrence and poor survival in triple-negative breast cancer
Researchers examine the association between patient-derived xenograft with recurrence and survival rates in triple negative breast cancer patients.